Close Menu

NEW YORK – Thermo Fisher Scientific today reported a 4 percent increase in second-quarter revenues, driven by growth across its business segments.

The Waltham, Massachusetts-based company had revenues of $6.32 billion in Q2, up 4 percent from $6.08 billion in the year-ago quarter and just beating the average Wall Street estimate of $6.3 billion. Organic revenues grew 5 percent, acquisitions increased revenue by 1 percent, and currency effects decreased revenue by 2 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

New research shows that scientists need to do a better job of including a wider diversity of African genomes in their analyses, STAT says.

A new paper in Science shows that men are still winning a large majority of the most sought-after NIH grants.

Nature Research and the Estée Lauder Companies are awarding efforts to encourage girls to pursue careers in the STEM fields.

In Science this week: beneficial genetic variants inherited from archaic Neanderthal and Denisovan hominins, and more.